Novel DAP kinase Inhibitors for Stroke & Heart Diseases
(Business Models : Co-development or licensing)
 
Provide novel kinase Inhibitors with SAR (patent filed).
Compounds have highly enzyme-selectivity.
To Start optimization of drug candidates.
Kinase programs are performed withPharmaDesign
(http://www.pharmadesign.co.jp/)
Research Program for COPD, Aneurysm and Wrinkle
(Business Models : Contract research or Co-development)
 
Provide drug screening program for DANCE protein.
Provide DANCE antibody used for unique diagnostic product developments.
Provide drug screening program for MMP protein.
 
 Nature. 2002 Jan 10;415(6868):171-5.
Fibulin-5/DANCE is essential for elastogenesis in vivo